ES2654344T3 - Cisteína y anorexia asociada con el envejecimiento - Google Patents

Cisteína y anorexia asociada con el envejecimiento Download PDF

Info

Publication number
ES2654344T3
ES2654344T3 ES11770786.9T ES11770786T ES2654344T3 ES 2654344 T3 ES2654344 T3 ES 2654344T3 ES 11770786 T ES11770786 T ES 11770786T ES 2654344 T3 ES2654344 T3 ES 2654344T3
Authority
ES
Spain
Prior art keywords
cysteine
aging
anorexia associated
weight
diet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11770786.9T
Other languages
English (en)
Spanish (es)
Inventor
Denis Breuille
Isabelle Papet
Karine Vidal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Institut National de la Recherche Agronomique INRA
Original Assignee
Nestec SA
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43304791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2654344(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec SA, Institut National de la Recherche Agronomique INRA filed Critical Nestec SA
Application granted granted Critical
Publication of ES2654344T3 publication Critical patent/ES2654344T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES11770786.9T 2010-10-21 2011-10-19 Cisteína y anorexia asociada con el envejecimiento Active ES2654344T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10188399A EP2444083A1 (en) 2010-10-21 2010-10-21 Cysteine and food intake
EP10188399 2010-10-21
PCT/EP2011/068231 WO2012052463A1 (en) 2010-10-21 2011-10-19 Cysteine and food intake

Publications (1)

Publication Number Publication Date
ES2654344T3 true ES2654344T3 (es) 2018-02-13

Family

ID=43304791

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11770786.9T Active ES2654344T3 (es) 2010-10-21 2011-10-19 Cisteína y anorexia asociada con el envejecimiento

Country Status (15)

Country Link
US (1) US9233090B2 (enExample)
EP (2) EP2444083A1 (enExample)
JP (1) JP6160832B2 (enExample)
CN (1) CN103269697A (enExample)
AU (1) AU2011317627B2 (enExample)
BR (1) BR112013009709A2 (enExample)
CA (1) CA2815109C (enExample)
DK (1) DK2629769T3 (enExample)
ES (1) ES2654344T3 (enExample)
MX (1) MX2013004371A (enExample)
PH (1) PH12013500761A1 (enExample)
RU (1) RU2013123062A (enExample)
SG (1) SG189935A1 (enExample)
WO (1) WO2012052463A1 (enExample)
ZA (1) ZA201303656B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
AU2018373653B2 (en) * 2017-11-21 2024-09-12 Societe Des Produits Nestle S.A. Compositions and methods using oleuropein or curcumin for muscle quality and/or muscle mass
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
WO2020163188A1 (en) * 2019-02-08 2020-08-13 Imbria Pharmaceuticals, Inc. Compositions containing n-acetylcysteine conjugated to a tca cycle intermediate
JP7655224B2 (ja) * 2019-10-25 2025-04-02 味の素株式会社 筋質向上剤
AU2023349972A1 (en) 2022-09-30 2025-05-08 Evonik Operations Gmbh Probiotic composition for the treatment of malnutrition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665082A (en) * 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
JPS62286923A (ja) * 1986-06-04 1987-12-12 Takao Shinoda 貧食作用増強剤
JPH05294833A (ja) * 1991-04-15 1993-11-09 Takeda Chem Ind Ltd ビタミン含有保健剤
WO1993002682A1 (en) * 1991-08-06 1993-02-18 Labco Pharmaceuticals, Inc. Method and compositions for reducing craving for alcohol and stimulants
DE4229166A1 (de) * 1992-09-01 1994-03-03 Deutsches Krebsforsch Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse
FR2711529B1 (fr) 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
US5627152A (en) * 1995-01-18 1997-05-06 Telluride Pharmaceutical Corporation Method for increasing bodyweight
US5770217A (en) 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
RO119122B1 (ro) * 1998-02-02 2004-04-30 Dumitru Dobrescu Medicament geriatric
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
JP2004519241A (ja) * 2001-03-09 2004-07-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 高齢化に伴う生理的障害を改善し寿命を延ばす組成物
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
WO2006134135A2 (en) 2005-06-14 2006-12-21 Nestec S.A. Nutritional method for elderly people
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤
JP2009001507A (ja) * 2007-06-19 2009-01-08 Ss Pharmaceut Co Ltd 体脂肪減少剤およびその利用
WO2009157759A1 (en) * 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
TWI515005B (zh) 2008-09-12 2016-01-01 ２４５８７８１加拿大公司 在接受化療或放療的患者中應用富含半胱胺酸之乳清衍生蛋白以增進患者存活時間
ES2621936T3 (es) 2008-10-17 2017-07-05 Nestec S.A. Método para preparar composiciones de proteína de suero de leche

Also Published As

Publication number Publication date
JP2014504261A (ja) 2014-02-20
PH12013500761A1 (en) 2017-08-23
WO2012052463A1 (en) 2012-04-26
US20130225486A1 (en) 2013-08-29
CA2815109C (en) 2020-03-24
DK2629769T3 (en) 2018-01-02
ZA201303656B (en) 2014-11-26
EP2629769B1 (en) 2017-10-04
US9233090B2 (en) 2016-01-12
EP2444083A1 (en) 2012-04-25
JP6160832B2 (ja) 2017-07-12
RU2013123062A (ru) 2014-11-27
MX2013004371A (es) 2013-08-27
AU2011317627B2 (en) 2016-06-02
SG189935A1 (en) 2013-06-28
CN103269697A (zh) 2013-08-28
AU2011317627A1 (en) 2013-05-23
BR112013009709A2 (pt) 2016-07-19
CA2815109A1 (en) 2012-04-26
EP2629769A1 (en) 2013-08-28

Similar Documents

Publication Publication Date Title
ES2654344T3 (es) Cisteína y anorexia asociada con el envejecimiento
MX2013012230A (es) Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas.
UY37998A (es) Agentes antivirales contra la hepatitis b
AR067555A1 (es) Derivado de peptido insulinotropico en el cual se modifica su aminoacido n- terminal
MX346745B (es) Aumento o mantenimiento no medico del peso corporal de un mamifero.
AR095104A1 (es) Método para disminuir el dolor articular inducido por el ejercicio en mamíferos no artríticos
UY32601A (es) Formulación en lípidos estabilizada de un promotor de la apoptosis
AR092571A1 (es) Composiciones saborizadas con mejor sabor y/o vida util del saborizante
RU2012139658A (ru) Композиции и способы для доставки питательных веществ
AR053803A1 (es) Uso de acido pinolenico
AR098653A1 (es) Composición útil para promover la fertilidad femenina, composición de combinación
AR109799A1 (es) Composición para el tratamiento del cabello
Poppi et al. Redefining the requirement for total sulfur amino acids in the diet of barramundi (Lates calcarifer) including assessment of the cystine replacement value
MX2016000187A (es) Composiciones y metodos para mejorar el rendimiento del ejercicio.
JP2010275318A5 (enExample)
MX2020007760A (es) Composiciones y metodos para mejorar la biodisponibilidad de 5-hidroxitriptofano.
IN2015DN03883A (enExample)
AR083460A1 (es) Hidrolizados de proteinas animales de origen marino con propiedades neuroprotectoras
BR112019008749A2 (pt) composição nutricional para uso na terapia de pacientes com câncer
RU2010110718A (ru) Способ профилактики и снижения деструкции цитоскелетных белков скелетных мышц при их атрофии, вызванной гипокинезией и/или гравитационной разгрузкой
UA85259U (ru) Средство для ревитализации и биорепарации периапикальных и мягких тканей полости рта
AR124611A1 (es) Composiciones y métodos para el tratamiento de enfermedades hepáticas asociadas con una o ambas entre hiperamonemia o pérdida muscular
UA107351C2 (en) Stabilized lipid formulation of apoptosis promoter
RU2012146985A (ru) Композиция для улучшения состояния при гипоальбуминемии
PL400151A1 (pl) Kompozycja dietetyczna do redukcji masy ciala oraz zastosowanie aminokwasów egzogennych do wytwarzania kompozycji dietetycznej